Xueqing Q. Lun

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Distinct spatial N-glycan profiles reveal glioblastoma-specific signatures.

Distinct spatial N-glycan profiles reveal glioblastoma-specific signatures.

Journal: The Journal of pathology

Published: July 29, 2024

Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR.

Impaired migration and lung invasion of human melanoma by a novel small molecule targeting the transmembrane domain of death receptor p75NTR.

Journal: EMBO molecular medicine

Published: December 11, 2023

Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.

Spatiotemporal modeling reveals high-resolution invasion states in glioblastoma.

Journal: Genome biology

Published: December 08, 2023

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma.

Journal: Nature communications

Published: November 19, 2021

Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells.

Human SNF5 arming of double-deleted vaccinia virus shows oncolytic and cytostatic activity against central nervous system atypical teratoid/rhabdoid tumor cells.

Journal: Cancer gene therapy

Published: March 24, 2020

Development of a peptide-based delivery platform for targeting malignant brain tumors.

Development of a peptide-based delivery platform for targeting malignant brain tumors.

Journal: Biomaterials

Published: December 15, 2019

Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.

Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 01, 2019

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression.

Journal: Nature communications

Published: October 25, 2018

Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Journal: Nature communications

Published: July 19, 2018

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.

ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.

Journal: PloS one

Published: May 25, 2018

Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro.

Temozolomide resistant human brain tumor stem cells are susceptible to recombinant vesicular stomatitis virus and double-deleted Vaccinia virus in vitro.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 05, 2016

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Journal: Nature communications

Published: June 30, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026